Mon. November 7, 2022 – Mon. January 16, 2023.
Fri. March 31, 2023.
Fri. April 28, 2023
※Regarding the submission for the symposium will be posted at a later date.
※Late Breaking Clinical Trial application is now open. (Submission deadline: May 19, 2023)
All submissions must be made online via this website.
If author and co-authors for this registration belong to overseas affiliations, they are not required to be a member of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT). However, if the author/co-author belongs to an institution in Japan, membership registration to CVIT by the meeting dates is required.
01 | Oral (English) |
02 | Oral (Japanese) |
03 | Poster (English) |
04 | Poster (Japanese) |
05 | Symposium /Panel Discussion *Submission for the symposium will be posted at a later date |
01 | ACS |
02 | Antiplatelet Therapy |
03 | Aortic valve intervention (TAVI/Valvuloplasty) |
04 | Bifurcated Lesion |
05 | BMS/BRS |
06 | CABG vs. PCI vs. OMT |
07 | CKD/HD |
08 | Closure device (PFO/ASD/LA appendage/PDA) |
09 | CLTI |
10 | Complications |
11 | COVID-19 |
12 | Congenital Heart Disease |
13 | CT/MRI/Scintigraphy |
14 | CTEPH/BPA/PH |
15 | CTO |
16 | DEB |
17 | DES |
18 | Diabetes |
19 | Distal Protection Devices/Thrombectomy |
20 | Dyslipidemia/HT/Smoking/Other Risk Factors |
21 | Emergency Care |
22 | Endovascular Intervention (Carotid/Subclavian/acute stroke) |
23 | Endovascular Intervention (Thoracic/Abdominal) |
24 | Endovascular Intervention (Shunt for HD) |
25 | Endovascular Intervention (Iliac/Femoral/BTK) |
26 | Epidemiology/Financial cost |
27 | Flow Wire/Pressure Wire/FFR CT |
28 | Guiding catheter |
29 | Heart Failure |
30 | ICD/CRT/CRTD/Electrophysiology |
31 | IVUS/OCT/Angioscopy |
32 | Kawasaki Disease |
33 | Laser Angioplasty |
34 | LMT |
35 | Mechanical circulatory support (IABP/ECMO/Impella) |
36 | Mitral Valve Intervention |
37 | Multivessel Disease |
38 | Pathology |
39 | Peripheral Artery Disease (PAD) |
40 | POBA/Cutting Balloon/Scoring Device |
41 | Prognosis |
42 | PTSMA |
43 | Pulmonary Embolism/DVT/Venous disease |
44 | Radial access/distal radial access |
45 | Regenerative Therapy |
46 | Renal Denervation |
47 | Restenosis/ISR |
48 | Rotablator/OAS/DCA |
49 | Secondary Prevention/OMT |
50 | Slender PCI/Less invasive strategy |
51 | Small Vessel Disease/Diffuse Lesion |
52 | Stent Thrombosis |
53 | Thrombolysis |
54 | Others |
Body of Abstract: 220 words or less including spaces and punctuations without any image (picture, chart or diagram).
130 words or less including spaces and punctuations with an image (picture, chart or diagram) in your abstract.
Abstract Submission
Note 1: Safari can be used with ver.2.0.3 (417.9.2) or later versions. Versions less than the above cannot be used.
Note 2: For security reasons, if you do not proceed to the next screen within 120 minutes, the session will time out.
The CVIT2023 entrusts the collecting, storing, and handling of the personal information provided to us, to Proactive Inc.
The personal information that you provide through the online submission system, will be used for the following purposes only:
- to answer your inquiries regarding the meeting.
- to send you the notification of review results.
- to post your names, affiliations, presentation titles and abstracts on the official website and publish the program book / meeting APP.
If author and co-authors for this registration belong to overseas affiliations, they are not required to be a member of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT). However, if the author/co-author belongs to an institution in Japan, membership registration to CVIT by the meeting dates is required.
The Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT)
TEL: +81-3-6280-4126
FAX: +81-3-6280-4127
E-mail: info@cvit.jp
CVIT website (Japanese only): http://www.cvit.jp/
Please download and fill in the Abstract Submission Form and send it to the Secretariat by e-mail (cvit2023@convention.co.jp). Submission deadline: Friday, May 19, 2023
E-mail: cvit2023@supportoffice.jp